January 22, 2021
OncoRes Medical receives $150,000 funding boost from Western Australian Government
Read moreOncoRes Medical receives $150,000 funding boost from Western Australian Government
Read moreMyricx Pharma Launches with £4.5M (AU$8.2M) Financing to Progress its Novel NMT inhibitors in Cancer
Read moreVaxxas Announces US$22 Million (A$30.6 Million) Award from U.S. Government to Advance Vaxxas Needle-Free HD-MAP™ Vaccine Patch Technology for Pandemic Response
Read moreHarro Höfliger and Vaxxas Announce Alliance to Develop Industrial‐scale Aseptic Processing Line for Vaccine Products Based on Vaxxas’ High Density Microarray Patch (HD‐MAP)
Read moreQUE Oncology Appoints Dr. Julie Cherrington and Elizabeth Cermak to Board of Directors
Read moreMRCF launches Perth-based biotech developing new treatment for Cystic Fibrosis
Read moreMRCF invests in San Diego ophthalmic biotech company, clinical trials to take place in Australia
Read moreAustralian biotech company launched with AU$7m investment to develop therapies for treating obesity
Read moreSuite 3.02, 56 Pitt Street
Sydney NSW 2000
Phone +61 2 8227 7080
PO Box R1168, Royal Exchange NSW 1225
Damon Birrell
Caleb Hulme-Moir